PeptidePedia The community reference

Contributions of PeakShapePol

User contributions·31 logged edits·page 1 of 1

Contributions by PeakShapePol, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,755 edits includes activity predating the current log.

  1. 22:58, 17 Jul 2026 (diff | hist) GL Biochem (Shanghai) 16,491 ±0 m split §Operations from §Product range
  2. 15:28, 14 Jul 2026 (diff | hist) Patent expiry and biosimilars 4,553 ±0 add the jurisdiction to the legal statement
  3. 17:12, 12 May 2026 (diff | hist) LEADER trial 4,799 ±0 ce, tighten prose
  4. 02:07, 26 Apr 2026 (diff | hist) Area percent purity 8,537 ±0 state the titration endpoint and the reagent factor
  5. 14:00, 18 Apr 2026 (diff | hist) Talk:Janoshik Analytical 748 +164 /* Chromatogram-reading table */ reply
  6. 17:54, 31 Mar 2026 (diff | hist) Retention time 4,104 ±0 split §Principle from §Practical limitations
  7. 16:46, 27 Feb 2026 (diff | hist) Reference standard 5,217 ±0 clarify that area percent is not mass percent
  8. 17:03, 21 Feb 2026 (diff | hist) Peptide content 8,404 ±0 m correct the water-content figure — the source reports it on a dry basis
  9. 14:36, 30 Jan 2026 (diff | hist) USP General Chapter 71 4,657 ±0 m fix a broken wikilink
  10. 18:36, 19 Jan 2026 (diff | hist) Loss on drying 4,874 ±0 add the sample preparation, since the result depends on it
  11. 05:03, 25 Dec 2025 (diff | hist) Regulatory status by jurisdiction 4,444 ±0 m add the date the shortage listing ended
  12. 05:17, 11 Aug 2025 (diff | hist) Retention time 3,764 ±0 m add the plate-count expression and define its terms
  13. 06:42, 19 Jun 2025 (diff | hist) USP General Chapter 71 4,070 +707 expand §What the chapter specifies
  14. 15:12, 4 Jun 2025 (diff | hist) High-performance liquid chromatography 6,203 ±0 m split §Principle from §Practical limitations
  15. 08:53, 16 May 2025 (diff | hist) Sterility testing 3,636 ±0 unpipe a link that did not need piping
  16. 20:03, 13 Apr 2025 (diff | hist) Peptide aggregation 4,377 ±0 add the forced-degradation conditions the claim rests on
  17. 09:18, 20 Feb 2025 (diff | hist) Talk:Area percent purity 959 +121 /* Detection wavelength: 214 or 220? */ reply
  18. 15:39, 29 Jan 2025 (diff | hist) Resin cleavage 3,277 +196 m add the crimp-seal step to the fill-and-finish description
  19. 08:45, 22 Jan 2025 (diff | hist) Electrospray ionisation 3,226 +111 m add the reference standard and its traceability
  20. 13:39, 28 Dec 2024 (diff | hist) Mass spectrometry 4,327 +26 de-duplicate a repeated sentence
  21. 09:23, 24 Nov 2024 (diff | hist) Chinese Peptide Company 6,679 +782 add the note that self-published material is usable only for what it states about itself
  22. 19:20, 12 Nov 2024 (diff | hist) Nantong Guangyuan Chemical 6,450 +201 add the incorporation year, attributed to the registry record
  23. 19:45, 28 Oct 2024 (diff | hist) Trifluoroacetate counterion 2,713 +343 m add the sample preparation, since the result depends on it
  24. 01:58, 28 Oct 2024 (diff | hist) Timeline of incretin therapeutics 2,352 ±0 fix indentation in the source
  25. 18:51, 25 Oct 2024 (diff | hist) Peptide content 3,491 +537 convert the method-comparison paragraph to a table
  26. 10:37, 19 Oct 2024 (diff | hist) Cold chain 11,453 +163 add the figure for the lyophilisation cycle and caption it
  27. 04:24, 5 Oct 2024 (diff | hist) Analytical method validation 2,979 ±0 expand §The characteristics
  28. 17:26, 20 Sep 2024 (diff | hist) Dulaglutide 1,910 ±0 m the half-life in the lead was the terminal figure; label it as such
  29. 01:30, 7 Sep 2024 (diff | hist) Peptide content 1,273 +1,273 N start article on the analytical method
  30. 21:17, 25 Aug 2024 (diff | hist) Retention time 986 ±0 add the forced-degradation conditions the claim rests on
  31. 03:48, 22 Jun 2024 (diff | hist) High-performance liquid chromatography 2,129 ±0 add the figure for the chromatogram and caption its axes